Predict your next investment

Metabolon company logo
Corporation
HEALTHCARE | Biotechnology
metabolon.com

See what CB Insights has to offer

Total Raised

$183M

Investors Count

13

Deal Terms

7

Metabolon Funding, Metabolon Valuation & Metabolon Revenue

16 Fundings

Metabolon's latest funding round was a Debt - II for $50.23M on September 23, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/23/2020

Debt - II

$50.23M

Undisclosed Investors

2

9/11/2020

Unattributed VC

$21.77M

2

4/8/2020

Loan

$3.5M

8/13/2019

Debt

$99M

10

8/15/2018

Series E - IV

$99M

10

Date

9/23/2020

9/11/2020

4/8/2020

8/13/2019

8/15/2018

Round

Debt - II

Unattributed VC

Loan

Debt

Series E - IV

Amount

$50.23M

$21.77M

$3.5M

$99M

$99M

Investors

Undisclosed Investors

Valuation

Revenue

Sources

2

2

10

10

Metabolon Deal Terms

7 Deal Terms

Metabolon's deal structure is available for 7 funding rounds, including their Series E - III from August 11, 2016.

Round

Series E - III

Series E - II

Series D

Series C - III

Series C

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

Post-Money Valuation

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

$99M

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

$99M

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series E - III

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series E - II

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series D

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C - III

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series C

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Metabolon Investors

13 Investors

Metabolon has 13 investors. Sevin Rosen Funds invested in Metabolon's Unattributed VC funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

10/15/2004

9/11/2020

10
Series C, Series B (2006), Series A (2004), Series C - II (2009), Series C - III (2009), Series D (2011), Series E (2013), Series E - II (2015), Series E - IV (2018), Unattributed VC (2020)

John Oxaal

Venture Capital

Texas

4/10/2009

9/11/2020

8
Series C, Series C - II (2009), Series C - III (2009), Series D (2011), Series E (2013), Series E - II (2015), Series E - IV (2018), Unattributed VC (2020)

Guy Fish

Corporate Venture

Massachusetts

4/10/2009

9/11/2020

8
Series C, Series C - II (2009), Series C - III (2009), Series D (2011), Series E (2013), Series E - II (2015), Series E - IV (2018), Unattributed VC (2020)

Carol Marino, and David Pierson

Corporate Venture

Switzerland

00/00/0000

00/00/0000

EW Healthcare Partners

Subscribe to see more

Subscribe to see more

Growth Equity

New York

00/00/0000

00/00/0000

Perceptive Advisors

Subscribe to see more

Hedge Fund

New York

First funding

10/15/2004

4/10/2009

4/10/2009

00/00/0000

00/00/0000

Last Funding

9/11/2020

9/11/2020

9/11/2020

00/00/0000

00/00/0000

Investor

EW Healthcare Partners

Perceptive Advisors

Rounds

10
Series C, Series B (2006), Series A (2004), Series C - II (2009), Series C - III (2009), Series D (2011), Series E (2013), Series E - II (2015), Series E - IV (2018), Unattributed VC (2020)
8
Series C, Series C - II (2009), Series C - III (2009), Series D (2011), Series E (2013), Series E - II (2015), Series E - IV (2018), Unattributed VC (2020)
8
Series C, Series C - II (2009), Series C - III (2009), Series D (2011), Series E (2013), Series E - II (2015), Series E - IV (2018), Unattributed VC (2020)

Subscribe to see more

Subscribe to see more

Board Seats

John Oxaal

Guy Fish

Carol Marino, and David Pierson

Subscribe to see more

Type

Venture Capital

Corporate Venture

Corporate Venture

Growth Equity

Hedge Fund

Location

Texas

Massachusetts

Switzerland

New York

New York

Metabolon Acquisitions

2 Acquisitions

Metabolon acquired 2 companies. Their latest acquisition was Metabolomic Discoveries on September 05, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

9/5/2017

$99M

Acquired

3

8/3/2012

Series C

Subscribe to see more

$99M

$99M

Subscribe to see more

0

Date

9/5/2017

8/3/2012

Investment Stage

Series C

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acquired

Subscribe to see more

Sources

3

0

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.